Nutrient Composition Synergistic Neurodevelopment via HMO MFGM Choline
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a composition that effectively promotes brain development and intelligence in infants and young children, particularly by enhancing neurodevelopment processes such as neuron maturation, synaptogenesis, and myelination, which are critical for optimal cognitive function and connectivity in the central nervous system.
Innovation Solution
A nutrient composition comprising human milk oligosaccharides, specifically neutral fucosylated human milk oligosaccharides like 2′-fucosyl lactose, milk fat globule membrane, and choline or edible choline derivatives, which synergistically promote oligodendrocyte precursor cell proliferation, maturation, and differentiation, and myelination when combined.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a nutrient composition is designed to promote brain development and intelligence in infants, then neurodevelopmental processes such as neuron maturation, synaptogenesis, and myelination are enhanced, but the complexity of the composition increases and requires multiple components to work synergistically
Solution Approach 1:
The patent combines three specific nutrient components (human milk oligosaccharides, milk fat globule membrane, and choline) into a single integrated composition. The specification states that these components work synergistically to promote oligodendrocyte precursor cell proliferation, maturation, and myelination, achieving enhanced brain development effects that exceed the sum of individual components.
Solution Approach 2:
The invention creates a composite nutrient composition with specific ratios of different bioactive substances. The specification defines precise compositional ranges for each component (HMOs at 0.01-5% w/w, MFGM at 0.1-3% w/w, choline at 0.01-1% w/w) to optimize the synergistic effect on neurodevelopment while maintaining compositional control.
2Reliability
If the nutrient composition includes specific ratios of multiple components, then the synergistic effect on oligodendrocyte precursor cell proliferation and myelination is maximized, but the manufacturing precision requirements increase
Solution Approach 1:
The patent specifies optimal concentration ranges for each component to achieve synergistic effects. The specification provides detailed parameter windows (HMOs: 0.01-5% w/w, MFGM: 0.1-3% w/w, choline: 0.01-1% w/w) that balance manufacturing feasibility with biological effectiveness, allowing flexible formulation while maintaining synergistic action.
3Reliability
If human milk oligosaccharides are used to promote neurodevelopment, then oligodendrocyte precursor cell maturation is enhanced, but the cost of the composition increases due to the specialized nature of HMOs
Solution Approach 1:
The patent targets specific neurodevelopmental processes with specific components. The specification indicates that HMOs are particularly effective for promoting oligodendrocyte precursor cell maturation and myelination, while choline supports membrane formation and MFGM provides structural components. This targeted approach optimizes cost-effectiveness by matching specific nutrients to specific developmental needs.
Data Source
AI summary
The invention relates to a nutrient composition, a food including the same and use of the nutrient composition. The nutrition composition includes: human milk oligosaccharide, preferably neutral fucosylated human milk oligosaccharide, which is preferably one or more selected from the group consisting of: 2′-fucosyl lactose, 3′-fucosyl lactose, lacto-N-fucopentaose I, lacto-N-difucohexaose I, lacto-N-difucohexaose II, preferably 2′-fucosyl lactose (2′-FL); milk fat globule membrane; and choline and/or an edible choline derivative. The nutritional composition can improve the brain development and intelligence of babies, infants and young children, especially promote neurodevelopment such as neuron maturation, synaptogenesis and myelination.